Dana-Farber Cancer Insitute

Boston, Massachusetts 02215

We've found

1 trials

at this facility

Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Boston, MA

Use our guide to learn which trials are right for you!